Navigation Links
Cinpathogen Provides Clinical Diagnostic Consulting Services to Shanghai Area Hospitals
Date:1/3/2008

SHANGHAI, China, Jan. 3 /PRNewswire/ -- Cinpathogen, through its partnership in the Fudan-Cinpathogen Clinical and Molecular Research Center, has begun offering clinical diagnostic technology consulting services to Shanghai area hospitals. For the past four years as part of the Shanghai Health Study, the Center has diagnosed and characterized over 3000 cases of hematopoietic and lymphoid diseases in collaboration with area hospitals and colleagues at Fudan University, the University of Colorado at Denver and Health Sciences Center and the University of Cincinnati. By launching this service, Cinapthogen and the Institute of Biomedical Sciences at Fudan University are ensuring continuous development and enhancement of the clinical diagnostic capabilities in China.

"Though the research project has made a solid landing after seven years of extensive effort and participation, the Fudan-Cinpathogen Clinical and Molecular Research Center's mission will continue," said Professor Ouyang Renrong, former chairman of the Chinese Hematology and the Shanghai Hematology Societies. "The center, led by Dr. Richard Irons, will continue its journey in China to provide clinical services and research efforts in the field of hematology."

China is making research and development a priority and this move is aligned with the recent meeting of China's 17th Party Congress where continued scientific innovation was a major theme.

Cinpathogen is a major partner in the Fudan-Cinpathogen Clinical and Molecular Research Center at the Institutes of Biomedical Sciences at Fudan University, integrating basic and clinical research, modern diagnostic laboratories and access to one of the largest tissue banks dedicated to diseases of the blood and immune systems.

If you'd like more information about this topic or Cinpathogen, please contact Dr. Richard D. Irons at (303) 381-2543 or email him at contact@cinpathogen.com.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Cinpathogen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cinpathogen Brings Together Over 40 Shanghai Area Hospitals at the First Annual Cinpathogen Hematology Conference
2. CardioDynamics Provides 2007 Shareholder Meeting Update
3. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
4. NxStage Medical Provides Update on Medisystems Acquisition
5. VaxGen Files 2006 Financial Statements and Provides Cash Update
6. Signalife Provides Corporate Update
7. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
8. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
9. SGX Provides Update on BCR-ABL Collaboration
10. Intra-Cellular Therapies Provides Overview of its Proprietary Portfolio of Compounds for the Treatment of Female Sexual Dysfunction (FSD)
11. Pressure BioSciences, Inc. Provides Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... CA (PRWEB) , ... May 04, 2016 , ... ... excited to announce a strategic partnership with McGill University . The partnership is ... to the market in order to help patients in pain. With the new agreement, ...
(Date:5/4/2016)... York, NY (PRWEB) , ... May 04, 2016 ... ... has leveraged recent innovations in biotechnology to help treat hormonal and stress related ... loss, Nutrafol® has captured the hearts of key opinion leaders in the medical ...
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... ... announced the addition of Dr. Nancy Gillett to its Board of Directors. Dr. ... she served as Corporate Executive Vice President and Chief Scientific Officer. A board-certified ...
(Date:5/3/2016)... , ... May 03, 2016 , ... According to world ... for definitive prostate cancer treatment, patients traditionally had two main treatment options: surgery or ... would be made. , New technology has enabled doctors to administer higher doses ...
Breaking Biology Technology:
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
(Date:3/15/2016)... JERUSALEM , March 15, 2016 ... Jerusalem , the technology-transfer company of the Hebrew University, ... developer of remote sensing technology of various human biological ... funding, raising $2.0 million from private investors. ... technology, based on the detection of electromagnetic emissions from ...
Breaking Biology News(10 mins):